These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 13592006)

  • 1. [Therapeutic importance of sulfamethoxypyridine].
    Riforma Med; 1958 Aug; 72(34):959-60. PubMed ID: 13592006
    [No Abstract]   [Full Text] [Related]  

  • 2. ELISA for sulfonamides and its application for screening in water contamination.
    Shelver WL; Shappell NW; Franek M; Rubio FR
    J Agric Food Chem; 2008 Aug; 56(15):6609-15. PubMed ID: 18616276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [THERAPEUTIC EFFECTS OF SULURETIC SULFONAMIDES IN DIABETES INSIPIDUS].
    VENTURA E; VECCHI GP
    Minerva Med; 1963 Jul; 54():2122-31. PubMed ID: 14057934
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic lanthanide fluoroimmunoassay for the simultaneous screening of 18 sulfonamides using an engineered antibody.
    Korpimäki T; Hagren V; Brockmann EC; Tuomola M
    Anal Chem; 2004 Jun; 76(11):3091-8. PubMed ID: 15167787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic use of new sulfonamides].
    KLAUSGRABER F
    Wien Med Wochenschr; 1959 Jun; 109(23):485-7. PubMed ID: 13669484
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of sulfonamides to increase the therapeutic effectiveness of penicillin in the treatment of streptococcal infections.
    BREESE BB; DISNEY FA; TALPEY WB
    Pediatrics; 1959 May; 23(5):945-7. PubMed ID: 13645130
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass spectrometric studies of some novel sulfonamides.
    Haskins CM; Haskins NJ; Knight DW
    Rapid Commun Mass Spectrom; 2004; 18(1):44-8. PubMed ID: 14689558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic trials of metazolamide in spasmophilia].
    BOULET P; BARJON P; VALLAT G; FABRE S
    Sem Hop Ther Paris; 1963 Feb; 39():117-9. PubMed ID: 14014389
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Some recent therapeutic aspects in nephrology].
    TAMALET LJ
    Presse Therm Clim; 1963; 100():74-8. PubMed ID: 13990261
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on therapeutic alterability of experimental liver cirrhosis in rats. IV. Alteration of tetrachloride cirrhosis by liver extracts, lipocaic, sulfonamide derivatives and sulfhydryl compounds].
    KREY WD; HESSE L; WIRTZ M; CREUTZFELDT W; KUHN HA
    Z Gesamte Exp Med; 1963; 136():535-42. PubMed ID: 14035774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physicochemical and biological studies on sulfonamides. 1. Pharmacologically interesting physicochemical characteristics of 21 sulfonamides and 6 sulfonamide metabolites].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():81-8. PubMed ID: 13982261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physicochemical and biological studies on sulfonamides. 3. Relation between some physicochemical properties of sulfonamides and their fate in human and animal bodies].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():95-103. PubMed ID: 13982263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physicochemical and biological studies on sulfonamides. 2. Protein-binding, pharmacokinetics and distribution of 5 sulfonamides in rabbits].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():89-95. PubMed ID: 13982262
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term treatment of pyelonephritis and urinary tract infections with a new combination of sulfonamides. Conditions for long-term treatment with sulfonamides].
    BUCHT H; JOSEPHSON B; HOLMGARD A; ORSTEN PA
    Nord Med; 1962 Sep; 68():1123-7. PubMed ID: 14016537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic uses of a new sulfonamide: sulfamethopyrazine].
    HOVHANNESSIAN-FAUVE L
    Gaz Med Fr; 1960 Jul; 67():1677-80. PubMed ID: 13716198
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicity and biodegradability of sulfonamides and products of their photocatalytic degradation in aqueous solutions.
    Baran W; Sochacka J; Wardas W
    Chemosphere; 2006 Nov; 65(8):1295-9. PubMed ID: 16750553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic activity of 2-sulfanilamido-3-methoxypyrazine in some dermatological diseases].
    CALIFANO A
    Minerva Med; 1961 May; 52():1817-9. PubMed ID: 13689962
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of substituted sulfonamides and thiazolidin-4-one derivatives as agonists of human constitutive androstane receptor.
    Küblbeck J; Jyrkkärinne J; Poso A; Turpeinen M; Sippl W; Honkakoski P; Windshügel B
    Biochem Pharmacol; 2008 Nov; 76(10):1288-97. PubMed ID: 18786510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of a broad specificity antibody for simultaneous detection of 13 sulfonamides at the maximum residue level.
    Korpimäki T; Brockmann EC; Kuronen O; Saraste M; Lamminmäki U; Tuomola M
    J Agric Food Chem; 2004 Jan; 52(1):40-7. PubMed ID: 14709011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.